Avoro Capital Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Avoro Capital Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,885,000	Closed	-$257M	–	51
2020 Q3	$257M	Buy	1,885,000 +5,000	+0.3%	+$532K	3.65%	6
2020 Q2	$182M	Buy	1,880,000 +445,000	+31%	+$37.1M	3.59%	9
2020 Q1	$67.3M	Sell	1,435,000 -105,000	-7%	-$6.73M	2.27%	17
2019 Q4	$112M	Sell	1,540,000 -12,700	-0.8%	-$770K	3.3%	12
2019 Q3	$81M	Buy	1,552,700 +177,700	+13%	+$9.45M	3.38%	11
2019 Q2	$68.9M	Buy	1,375,000 +375,000	+38%	+$18.3M	2.38%	15
2019 Q1	$52M	Buy	+1,000,000	New	+$46.1M	2.25%	13
2018 Q1	–	Sell	-398,207	Closed	-$16.8M	–	63
2017 Q4	$16.8M	Hold	398,207	–	–	1.09%	23
2017 Q3	$17.1M	Buy	+398,207	New	+$12.7M	1.32%	23

Avoro Capital Advisors's MYOK Position: Q4 2020 in Review

Avoro Capital Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,885,000 shares — an estimated $257M sold.

Avoro Capital Advisors first reported a position in MYOK in Q3 2017 and held it in 9 quarters. The position peaked at $257M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Avoro Capital Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Avoro Capital Advisors sold 1,885,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $257M.
Avoro Capital Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Avoro Capital Advisors's MyoKardia, Inc. Common Stock position peaked at $257M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Avoro Capital Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.